Envestnet Asset Management
ONCS

Envestnet Asset Management’s OncoSec Medical Incorporated ONCS Stock Holding History

Envestnet Asset Management’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-955
Closed -$45K – 4003
2021
Q3 		$45K Buy
955
+342
+56% +$17.3K ﹤0.01% 3644
2021
Q2 		$38K Buy
+613
New +$55.6K ﹤0.01% 3611

Other funds holding ONCS

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Envestnet Asset Management's ONCS Position: Q4 2021 in Review

Envestnet Asset Management sold out of OncoSec Medical Incorporated (ONCS) in Q4 2021, closing a stake of 955 shares — an estimated $45K sold.

Envestnet Asset Management first reported a position in ONCS in Q2 2021 and held it in 2 quarters. The position peaked at $45K in Q3 2021. 34 funds tracked by Wall St. Rank hold ONCS as of Q4 2021.

  • Envestnet Asset Management reported no remaining OncoSec Medical Incorporated position as of Q4 2021 after selling out during the quarter.
  • Envestnet Asset Management sold 955 OncoSec Medical Incorporated shares in Q4 2021, an estimated $45K.
  • Envestnet Asset Management first reported a position in OncoSec Medical Incorporated in Q2 2021 and held it in 2 quarters.
  • Envestnet Asset Management's OncoSec Medical Incorporated position peaked at $45K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2021.

Based on Envestnet Asset Management's 13F filing for Q4 2021, filed 4 Feb 2022.